The Effect of Terlipressin on Renal Replacement Therapy in Patients with Hepatorenal Syndrome

KEY POINTS: Hepatorenal syndrome type 1 (HRS-1) is an often fatal, but potentially reversible, kidney failure in patients with decompensated cirrhosis. Treatment with terlipressin in patients with HRS-1 is associated with a reduction in the need for RRT. BACKGROUND: Hepatorenal syndrome type 1 (HRS-...

Descripción completa

Detalles Bibliográficos
Autores principales: Velez, Juan Carlos Q., Wong, Florence, Reddy, K. Rajender, Sanyal, Arun J., Vargas, Hugo E., Curry, Michael P., Gonzalez, Stevan A., Pappas, S. Chris, Jamil, Khurram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Nephrology 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482068/
https://www.ncbi.nlm.nih.gov/pubmed/37143199
http://dx.doi.org/10.34067/KID.0000000000000132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482068/
https://www.ncbi.nlm.nih.gov/pubmed/37143199
http://dx.doi.org/10.34067/KID.0000000000000132

Ejemplares similares